Cargando…

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model

BACKGROUND: Quantitative imaging can facilitate patient stratification in clinical trials. The hypoxia-activated prodrug evofosfamide recently failed a phase III trial in pancreatic cancer. However, the study did not attempt to select for patients with hypoxic tumors. We tested the ability of (18)F-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grkovski, Milan, Fanchon, Louise, Pillarsetty, Naga Vara Kishore, Russell, James, Humm, John L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005997/ https://www.ncbi.nlm.nih.gov/pubmed/29916085 http://dx.doi.org/10.1186/s13550-018-0409-1

Ejemplares similares

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma
por: Fanchon, Louise M., et al.
Publicado: (2020)

[(18)F]Fluoromisonidazole PET in rectal cancer
por: Puri, Tanuj, et al.
Publicado: (2017)

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET
por: Abdo, Redha-Alla, et al.
Publicado: (2019)

Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor
por: Russell, James, et al.
Publicado: (2022)

A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model()()
por: Hajj, Carla, et al.
Publicado: (2017)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

(18)F‐fluoromisonidazole uptake in advanced stage non‐small cell lung cancer: A voxel‐by‐voxel PET kinetics study
por: McGowan, Daniel R., et al.
Publicado: (2017)

Pretargeting of internalizing trastuzumab and cetuximab with a (18)F-tetrazine tracer in xenograft models
por: Keinänen, Outi, et al.
Publicado: (2017)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels–Alder Click Chemistry
por: Meyer, Jan-Philip, et al.
Publicado: (2015)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

Applications of nuclear-based imaging in gene and cell therapy: probe considerations
por: Volpe, Alessia, et al.
Publicado: (2021)

Kinetic analysis of dynamic (18)F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
por: Thorwarth, Daniela, et al.
Publicado: (2005)

Impact of fasting on (18)F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer
por: Wondergem, Maurits, et al.
Publicado: (2016)

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT
por: Maruyama, Koji, et al.
Publicado: (2021)

Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and (18)F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
por: MURAKAMI, MASAHIRO, et al.
Publicado: (2012)

CT abnormalities evocative of lung infection are associated with lower (18)F-FDG uptake in confirmed COVID-19 patients
por: Bahloul, Achraf, et al.
Publicado: (2020)

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma
por: Barajas, Ramon F., et al.
Publicado: (2015)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
por: Sabour, Siamak
Publicado: (2017)

Regional (18)F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma
por: Qin, Jianhua, et al.
Publicado: (2022)

Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients
por: Bourigault, Pauline, et al.
Publicado: (2022)

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study
por: Supiot, Stéphane, et al.
Publicado: (2018)

(18)F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
por: Reeves, Kirsten M., et al.
Publicado: (2022)

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
por: Gagel, Bernd, et al.
Publicado: (2006)

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
por: Nytko, Katarzyna J., et al.
Publicado: (2017)

Correlation of Tumor Hypoxia Metrics Derived from (18)F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

[(18)F]MPPF and [(18)F]FDG μPET imaging in rats: impact of transport and restraint stress
por: Buchecker, Verena, et al.
Publicado: (2020)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

Rapid detection of SARS-CoV-2 using a radiolabeled antibody
por: Pirovano, Giacomo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p088dm3pm30tn9f4m46fd6pqp8